B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

Status:
Not yet recruiting

Trial end date:
2024-09-08

Target enrollment:

Participant gender:

This is a clinical study to evaluate the safety and efficacy of CAR-T cells in the treatment of patients with advanced solid tumors in China.

Early Phase 1

The First People's Hospital of Lianyungang

Cyclophosphamide
Fludarabine